1/7/2013

Intrexon granted the Sanford-Burnham Medical Research Institute access to its Laser-Enabled Analysis and Processing instrument and RheoSwitch Therapeutic System. The technologies will help the research institute build its collection of human induced pluripotent stem cells. In return, Intrexon may get commercial and patent rights to technology developments arising from the collaboration.

Related Summaries